Document and Entity Information - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2022

Feb. 28, 2023

Jun. 30, 2022

Cover [Abstract]

Document Type

10-K

Amendment Flag

false

Document Period End Date

Dec. 31, 2022

Document Fiscal Year Focus

2022

Document Fiscal Period Focus

FY

Entity Registrant Name

ELIEM THERAPEUTICS, INC.

Entity Central Index Key

0001768446

Current Fiscal Year End Date

--12-31

Entity Filer Category

Non-accelerated Filer

Entity Shell Company

false

Entity Current Reporting Status

Yes

Entity Interactive Data Current

Yes

Entity Small Business

true

Entity Emerging Growth Company

true

Entity Ex Transition Period

false

Entity File Number

001-4078

Entity Incorporation, State or Country Code

DE

Entity Tax Identification Number

83-2273741

Entity Address, Address Line One

23515 NE Novelty Hill Road

Entity Address, Address Line Two

Suite B221 #125

Entity Address, City or Town

Redmond

Entity Address, State or Province

WA

Entity Address, Postal Zip Code

98053

City Area Code

1-877

Local Phone Number

354-3689

Document Annual Report

true

Document Transition Report

false

Title of 12(b) Security

Common Stock, par value $0.0001 per share

Trading Symbol

ELYM

Security Exchange Name

NASDAQ

Entity Common Stock, Shares Outstanding

26,567,681

Entity Well-known Seasoned Issuer

No

Entity Voluntary Filers

No

ICFR Auditor Attestation Flag

false

Documents Incorporated by Reference

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s definitive proxy statement for its 2023 Annual Meeting of Stockholders, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant’s fiscal year ended December 31, 2022, are incorporated by reference into Part III of this Annual Report on Form 10-K.

Auditor Name

PricewaterhouseCoopers LLP

Auditor Location

Seattle, Washington

Auditor Firm ID

238

Entity Public Float

$ 13.9